Skip to content

Effects of Parmigiano Reggiano on Skeletal Muscle Damage in Older Adults

Effects of Parmigiano Reggiano on Exercise Induced Muscle Damage in Older Adults

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04872374
Enrollment
20
Registered
2021-05-04
Start date
2021-05-01
Completion date
2022-03-01
Last updated
2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response, Muscle Soreness, Old Age; Atrophy

Brief summary

Aging is associated with the loss of muscle mass and function (sarcopenia) and reduced tissue regenerative capacity. Eccentric exercise (ECC) is a model of RET that can be used with the elderly, due to the ability of the muscle to combine high muscle strength production with low energy cost. ECC contractions are significantly more damaging to the muscles and produce greater muscle strength, for these reasons there is a greater risk of inducing muscle damage before the muscle is able to adapt. Parmigiano Reggiano (PR) has some peculiar bromatological characteristics. The proteins contained in it, and in particular the potentially bioactive peptide sequences, can rapidly provide the amino acids necessary to promote muscle growth and repair during exercise. Furthermore, PR can be an important source of fatty acids, of which a significant amount of short-chain fatty acids (SCFA) which are known to have important clinical effects on body composition and metabolic health and can have a systemic anti-inflammatory effect. Therefore, the central hypothes is that PR consumed during RET can provide more energy substrates and improve muscle recovery. To date, no studies have studied its function on recovery from exercise nor in the elderly.

Interventions

DIETARY_SUPPLEMENTParmigiano Reggiano

subjects will receive 50 g/die of the dietary supplement 10 days before performing the eccentric exercise session

DIETARY_SUPPLEMENTWhey Protein

subjects will receive 20 g/die of the dietary supplement 10 days before performing the eccentric exercise session

Sponsors

University of Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age \>60 years old or \>18 and \< 30 years old * BMI \>18 and \<30 kg/m2 * stable body weight in the past 3 months * valid medical certifacate for practice of physical activity

Exclusion criteria

* diabetes or pre-diabetes as for ADA guidelines * chronic diseases (cardiovascular, liver, respiratory, cancer, etc) * acute inflammatory status * regular practice of intense physical activity (\>2 sessions/week) * treatment with steroids in the past 3 months * regular use of \>50g/die of Parmigiano Reggiano

Design outcomes

Primary

MeasureTime frameDescription
maximum volountary contraction (MVC)Change from baseline to up to 5 daysmaximal muscle volountary contraction mesured in Newton

Secondary

MeasureTime frameDescription
reactive Proteinc CChange from baseline to up to 5 daysplasmatic levels of reactive Proteinc C (mg/dL) as a markers of muscle damage
Creatin KinaseChange from baseline to up to 5 daysplasmatic levels of Creatin Kinase (mmol/dL) as a markers of muscle damage
IL-6Change from baseline to up to 5 daysplasmatic levels of IL-6 (mg/dL) as a markers of muscle damage
delayed onset muscle soreness (DOMS)Change from baseline to up to 5 dayslevel of delayed onset muscle soreness (DOMS) masured via Visual Analogue Scale (VAS) scale where 0 is the minimal value (no pain) and 10 is the maximum value (maximum pain).

Countries

Italy

Contacts

Primary ContactTatiana Moro, PhD
tatiana.moro@unipd.it0498275306
Backup ContactAntonip Paoli, MD
antonio.paoli@unipd.it049825318

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026